#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5246745	B	Inhibition of N-terminal GST-fused human wild type LRRK2 using fluorescein-labeled LRRKtide as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by TR-FRET assay	Homo sapiens	40		single protein format	Scientific Literature
2.	ALA5246746	B	Inhibition of N-terminal GST-fused human LRRK2 G2019S mutant using fluorescein-labeled LRRKtide as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by TR-FRET assay	Homo sapiens	42		single protein format	Scientific Literature
3.	ALA5246747	B	Selectivity ratio of IC50 for inhibition of N-terminal GST-fused human wild type LRRK2 to IC50 for inhibition of N-terminal GST-fused human wild type LRRK2 G2019S mutant	Homo sapiens	42		assay format	Scientific Literature
4.	ALA5246748	B	Inhibition of human wild type LRRK2 expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation incubated for 2 hrs by HTRF analysis	Homo sapiens	8		cell-based format	Scientific Literature
5.	ALA5246749	B	Inhibition of human LRRK2 G2019S mutant expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation incubated for 2 hrs by HTRF analysis	Homo sapiens	8		cell-based format	Scientific Literature
6.	ALA5246750	B	Selectivity ratio of IC50 for inhibition of human wild type LRRK2 expressed in HEK293 cells to IC50 for inhibition of human LRRK2 G2019S mutant expressed in HEK293	Homo sapiens	8		cell-based format	Scientific Literature
7.	ALA5246751	B	Inhibition of human wild type LRRK2 expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation incubated for 2 hrs by immunoblotting analysis	Homo sapiens	3		cell-based format	Scientific Literature
8.	ALA5246752	B	Inhibition of human LRRK2 G2019S mutant expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation incubated for 2 hrs by immunoblotting analysis	Homo sapiens	3		cell-based format	Scientific Literature
9.	ALA5246753	B	Selectivity ratio of IC50 for inhibition of human wild type LRRK2 expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation to IC50 for inhibition of human LRRK2 G2019S mutant expressed in HEK293 cells assessed as reduction in pSer935 phosphorylation	Homo sapiens	3		cell-based format	Scientific Literature
10.	ALA5246754	B	Inhibition of human wild type LRRK2 expressed in HEK293 cells assessed as reduction in pS1292 phosphorylation incubated for 2 hrs by MSD analysis	Homo sapiens	8		cell-based format	Scientific Literature
11.	ALA5246755	B	Inhibition of human LRRK2 G2019S mutant expressed in HEK293 cells assessed as reduction in pS1292 phosphorylation incubated for 2 hrs by MSD analysis	Homo sapiens	8		cell-based format	Scientific Literature
12.	ALA5246756	B	Selectivity ratio of IC50 for inhibition of human wild type LRRK2 expressed in HEK293 cells assessed as reduction in pS1292 phosphorylation to IC50 for inhibition of human LRRK2 G2019S mutant expressed in HEK293 cells assessed as reduction in pS1292 phosphorylation	Homo sapiens	8		cell-based format	Scientific Literature
13.	ALA5246757	B	Inhibition human wild type LRRK2 expressed in human HEK293 assessed as Rab10 substrate phosphorylation at Threonine 73 residue incubated for 2 hrs by immunoblotting analysis	Homo sapiens	8		cell-based format	Scientific Literature
14.	ALA5246758	B	Inhibition human LRRK2 G2019S mutant expressed in human HEK293 assessed as Rab10 substrate phosphorylation at Threonine 73 residue incubated for 2 hrs by immunoblotting analysis	Homo sapiens	8		cell-based format	Scientific Literature
15.	ALA5246759	B	Selectivity ratio of IC50 for inhibition human wild type LRRK2 expressed in human HEK293 assessed as Rab10 substrate phosphorylation at Threonine 73 residue to IC50 for inhibition of human LRRK2 G2019S mutant expressed in human HEK293 assessed as Rab10 substrate phosphorylation at Threonine 73 residue	Homo sapiens	8		assay format	Scientific Literature